Expanding the structural resolution of glycosylation microheterogeneity in therapeutic proteins by salt-free hydrophilic interaction liquid chromatography tandem mass spectrometry

• Published in: mAbs Vol. 16; no. 1; p. 2395503
• Main Authors: Gan, Yutian, Lippold, Steffen, Stobaugh, John, Schöneich, Christian, Yang, Feng
• Format: Journal Article
• Language: English
• Published: United States Taylor & Francis Group 31.12.2024
• Subjects: Chromatography, Liquid - methods; Critical quality attribute; glycopeptide; Glycopeptides - analysis; Glycopeptides - chemistry; Glycopeptides - metabolism; Glycosylation; Humans; hydrophilic interaction liquid chromatography; Hydrophobic and Hydrophilic Interactions; mass spectrometry; Polysaccharides - analysis; Polysaccharides - chemistry; Protein Processing, Post-Translational; Tandem Mass Spectrometry - methods; glycopeptide; mass spectrometry; Critical quality attribute; hydrophilic interaction liquid chromatography
• ISSN: 1942-0862; 1942-0870; 1942-0870
• DOI: 10.1080/19420862.2024.2395503

Glycosylation affects the safety and efficacy of therapeutic proteins and is often considered a critical quality attribute (CQA). Therefore, it is important to identify and quantify glycans during drug development. Glycosylation is a highly complex post-translational modification (PTM) due to its structural heterogeneity, i.e. glycosylation site occupancy, glycan compositions, modifications, and isomers. Current analytical tools compromise either structural resolution or site specificity. Hydrophilic interaction liquid chromatography-fluorescence-mass spectrometry (HILIC-FLR-MS) is the gold standard for structural analysis of released glycans, but lacks information on site specificity and occupation. However, HILIC-FLR-MS often uses salt in the solvent, which impairs analysis robustness and sensitivity. Site-specific glycosylation analysis via glycopeptides, upon proteolytic digestion, is commonly performed by reversed-phase liquid chromatography-tandem mass spectrometry (RPLC-MS/MS), but provides only compositional and limited structural glycan information. In this study, we introduce a salt-free, glycopeptide-based HILIC-tandem mass spectrometry (HILIC-MS/MS) method that provides glycan identification, glycan isomer separation and site-specific information simultaneously. Moreover, HILIC-MS/MS demonstrated comparable relative quantification results as released glycan HILIC-FLR-MS. Further, our new method improves the retention of hydrophilic peptides, allowing simultaneous analysis of important CQAs such as deamidation in antibodies. The developed method offers a valuable tool to streamline the site-specific glycosylation analysis of glycoproteins, which is particularly important for the expanding landscape of novel therapeutic formats in the biopharmaceutical industry.